Mondria, T.

patient brain study level month sclerosis palatal myoclonus transplantation palatal baseline treatment cell transplantation myoclonu nfh-smi disease serum effect brain atrophy atrophy control chemotherapy neurol spms-bmt patients neurology autologou ahsct lingual 2 years spms-bmt protein group disability volume lingual myoclonus movement range change neurofilament activation sample nfh-smi 35 progression trial brain tissue loss imaging biomarker conditioning marrow blood disability status scale result disability progression petzold neurotoxicity research activity department follow-up oligoclonal palatal tremor dystonia lesion spms-pl method csf-scd protein fraction protocol tissue tremor placebo oligoclonal bands fig 4 b erasmus mc factor 3 months netherland marker image cancer blepharospasm